Education
About Us
Working with TipRanks
Follow Us
Thomas Charles Reilly Insider Profile
4 Followers
Thomas Charles Reilly, CFO at Tvardi Therapeutics, holds 94.31K shares in Amarin (Ticker: AMRN), holds 37.81K shares in Tvardi Therapeutics (Ticker: TVRD).
Thomas Charles Reilly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Charles Reilly holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Thomas Charles Reilly
Thomas Charles Reilly's Trading History
Tvardi Therapeutics
Mar 04, 2022
CFO
Uninformative Sell
23.26K
$147.08K
Amarin
Jul 01, 2024
EVP & CFO
Uninformative Buy
5.84K
$1.45M
List of latest transactions for each holding click on a transaction to see Thomas Charles Reilly's performance on stock
You May Also Like
Thomas Charles Reilly insider profile FAQ
What is the percentage of profitable transactions made by Thomas Charles Reilly?
The percentage of profitable transactions made by Thomas Charles Reilly is ―.
What is the average return per transaction made by Thomas Charles Reilly?
The average return per transaction made by Thomas Charles Reilly is ―.
What stocks does Thomas Charles Reilly hold?
Thomas Charles Reilly holds: TVRD, AMRN stocks.
What was Thomas Charles Reilly’s latest transaction?
Thomas Charles Reilly latest transaction was an Uninformative Buy of $5.84K.
What was Thomas Charles Reilly's most profitable transaction?
Thomas Charles Reilly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Thomas Charles Reilly's role in Tvardi Therapeutics?
Thomas Charles Reilly's role in Tvardi Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.